Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with lasting benefits and manageable side effects.

Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions – Biotech Investments

Spexis AG / Key word(s): Strategic Company Decision 30-Jun-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

July 1, 2023

Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence

January 8, 2024

Updated: Pfizer’s activist says board must ‘hold management accountable’ for R&D shortcomings

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.